MRM Health key facts
as of Oct 2026- Developer of a clinical-stage biopharmaceutical platform designed to create microbiome-based live biotherapeutic products to address chronic inflammatory diseases.
- MRM Health is valued at approximately $67.1M as of Oct 2026 (last reported valuation).
- It has raised $88.7M; the latest was Later Stage VC ($64.2M) in Sep 2025.
- Notable investors include Korys Investments, Société Fédérale de Participations et d'Investissement, VIB, BNP Paribas Fortis Private Equity, Ackermans & van Haaren — 15 tracked in total.
- Status: Privately Held (backing).
MRM Health's last reported valuation, Sep 2025. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch MRM Health: the Monday email on marks, rounds and moves
MRM Health funding rounds
No funding rounds for MRM Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs MRM Health
15+MRM Health valuation
MRM Health's last reported valuation was $67.1 million in Sep 2025. No priced round, secondary trade or fund mark has surfaced since.
MRM Health investors
15 investors are on record for MRM Health, including Korys Investments, Société Fédérale de Participations et d'Investissement, VIB and BNP Paribas Fortis Private Equity.
About MRM Health
Developer of a clinical-stage biopharmaceutical platform designed to create microbiome-based live biotherapeutic products to address chronic inflammatory diseases. The company offers a proprietary platform with advanced bioinformatics-guided strain design, optimized microbial consortia development and standardized manufacturing, enabling healthcare researchers and clinicians to explore new therapeutic approaches for patients with inflammatory bowel conditions and complex health challenges.
- Sector
- Healthcare
- HQ
- Ghent, Belgium
- Founded
- 2020
- Employees
- 41
- Website
- mrmhealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.